![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: ADRA2C (CAeditome ID:152) |
Gene summary for ADRA2C |
![]() |
Gene information | Gene symbol | ADRA2C | Gene ID | 152 |
Gene name | adrenoceptor alpha 2C | |
Synonyms | ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR | |
Cytomap | 4p16.3 | |
Type of gene | protein-coding | |
Description | alpha-2C adrenergic receptoradrenergic, alpha-2C-, receptoralpha-2 adrenergic receptor subtype C4alpha-2C adrenoceptoralpha-2C adrenoreceptoralpha-2CARalpha2-AR-C4 | |
Modification date | 20210518 | |
UniProtAcc | P18825 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
ADRA2C | GO:0004938 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0042803 | Alpha-2C adrenergic receptor | 16605244 |
ADRA2C | GO:0051379 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0007186 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0032148 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0035624 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0043410 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0045666 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0071875 | Alpha-2C adrenergic receptor | 17215105 |
ADRA2C | GO:0005737 | Alpha-2C adrenergic receptor | 16605244 |
ADRA2C | GO:0005887 | Alpha-2C adrenergic receptor | 16605244 |
Top |
RNA A-to-I events for ADRA2C |
![]() |
![]() |
![]() |
![]() |
CAediting_348238(3767091, +), CAediting_348239(3767112, +), CAediting_348240(3767117, +), |
Top |
RNA editing positional annotations for ADRA2C using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
CAediting_348238 | chr4_3767091_+ | nonsynonymous SNV | ENST00000330055.6 | c.A485G | p.K162R | D | P | N |
CAediting_348238 | chr4_3767091_+ | nonsynonymous SNV | ENST00000509482.1 | c.A485G | p.K162R | D | P | N |
CAediting_348239 | chr4_3767112_+ | nonsynonymous SNV | ENST00000330055.6 | c.A506G | p.K169R | D | D | D |
CAediting_348239 | chr4_3767112_+ | nonsynonymous SNV | ENST00000509482.1 | c.A506G | p.K169R | D | D | D |
![]() |
CAeditome ID | Position | Variant type |
CAediting_348238 | chr4_3767091_+ | exonic |
CAediting_348239 | chr4_3767112_+ | exonic |
CAediting_348240 | chr4_3767117_+ | exonic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
Top |
RNA A-to-I editing events in the alternative splicing sites for ADRA2C |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for ADRA2C |
![]() * The grey color means N/A. |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for ADRA2C |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for ADRA2C |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_1368054 | chr19_46709310_- | ENSG00000184160.7 | ENST00000330055 | hsa-miR-320e | 3768240 | 3768246 | 7mer-m8 | 3768230 | 3768247 | 154 | -22.13 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for ADRA2C |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
ENST00000330055.6 | protein_coding | ![]() | ![]() |
ENST00000509482.1 | protein_coding | ![]() | ![]() |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
CAediting_348238 | ENST00000330055.6 | chr4_3767091_+ | -1106.60 | -1104.20 | -1106.40 |
CAediting_348239 | ENST00000330055.6 | chr4_3767112_+ | -1104.40 | -1104.20 | -1106.40 |
CAediting_348240 | ENST00000330055.6 | chr4_3767117_+ | -1103.80 | -1104.20 | -1106.40 |
CAediting_348238 | ENST00000509482.1 | chr4_3767091_+ | -863.00 | -860.60 | -862.80 |
CAediting_348239 | ENST00000509482.1 | chr4_3767112_+ | -860.80 | -860.60 | -862.80 |
CAediting_348240 | ENST00000509482.1 | chr4_3767117_+ | -860.20 | -860.60 | -862.80 |
Top |
Relation with ADAR for ADRA2C |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for ADRA2C |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for ADRA2C |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for ADRA2C |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
ADRA2C | P18825 | DB00217 | Bethanidine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00246 | Ziprasidone | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00248 | Cabergoline | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00363 | Clozapine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00368 | Norepinephrine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00408 | Loxapine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00484 | Brimonidine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00502 | Haloperidol | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00540 | Nortriptyline | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00543 | Amoxapine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00575 | Clonidine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00696 | Ergotamine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00800 | Fenoldopam | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB00925 | Phenoxybenzamine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB01049 | Ergoloid mesylate | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB01175 | Escitalopram | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB01224 | Quetiapine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB01267 | Paliperidone | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB01365 | Mephentermine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB04855 | Dronedarone | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB04946 | Iloperidone | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB06153 | Pizotifen | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB06216 | Asenapine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB06707 | Levonordefrin | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB09167 | Dosulepin | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB09195 | Lorpiprazole | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB11124 | Racepinephrine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB11273 | Dihydroergocornine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB11278 | DL-Methylephedrine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB11577 | Indigotindisulfonic acid | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved |
ADRA2C | P18825 | DB13345 | Dihydroergocristine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|experimental |
ADRA2C | P18825 | DB01576 | Dextroamphetamine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|illicit |
ADRA2C | P18825 | DB01577 | Metamfetamine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|illicit |
ADRA2C | P18825 | DB00182 | Amphetamine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|illicit|investigational |
ADRA2C | P18825 | DB00193 | Tramadol | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00268 | Ropinirole | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00589 | Lisuride | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00697 | Tizanidine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00714 | Apomorphine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00715 | Paroxetine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00734 | Risperidone | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00934 | Maprotiline | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00935 | Oxymetazoline | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB01069 | Promethazine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB01136 | Carvedilol | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB01151 | Desipramine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB01200 | Bromocriptine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB01238 | Aripiprazole | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB01403 | Methotrimeprazine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB04846 | Celiprolol | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB06148 | Mianserin | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB06262 | Droxidopa | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB06694 | Xylometazoline | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB08815 | Lurasidone | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB09128 | Brexpiprazole | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB09205 | Moxisylyte | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB14185 | Aripiprazole lauroxil | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational |
ADRA2C | P18825 | DB00477 | Chlorpromazine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational|vet_approved |
ADRA2C | P18825 | DB01392 | Yohimbine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational|vet_approved |
ADRA2C | P18825 | DB01186 | Pergolide | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|investigational|vet_approved|withdrawn |
ADRA2C | P18825 | DB00433 | Prochlorperazine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|vet_approved |
ADRA2C | P18825 | DB00797 | Tolazoline | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|vet_approved |
ADRA2C | P18825 | DB00397 | Phenylpropanolamine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | approved|vet_approved|withdrawn |
ADRA2C | P18825 | DB11477 | Xylazine | Alpha-2C adrenergic receptor | SmallMoleculeDrug | vet_approved |
Top |
RelatedDiseases for ADRA2C |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
ADRA2C | C0005586 | Bipolar Disorder | 1 | PSYGENET |
ADRA2C | C0016059 | Fibrosis | 1 | CTD_human |
ADRA2C | C0018800 | Cardiomegaly | 1 | CTD_human |
ADRA2C | C0018801 | Heart failure | 1 | CTD_human |
ADRA2C | C0018802 | Congestive heart failure | 1 | CTD_human |
ADRA2C | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
ADRA2C | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
ADRA2C | C0525045 | Mood Disorders | 1 | PSYGENET |
ADRA2C | C1383860 | Cardiac Hypertrophy | 1 | CTD_human |
ADRA2C | C1623038 | Cirrhosis | 1 | CTD_human |
ADRA2C | C1959583 | Myocardial Failure | 1 | CTD_human |
ADRA2C | C1961112 | Heart Decompensation | 1 | CTD_human |